Trending Now
Protalix BioTherapeutics Inc. (NYSEAMERICAN: PLX) Releases Results of BRIGHT Phase III...
Protalix BioTherapeutics Inc. (NYSEAMERICAN: PLX) has announced final results from the BRIGHT third phase clinical study evaluating pegunigalsidase alfa for possible Fabry disease treatment.
PRX-102...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Is Loyalty Ventures Inc (LYLT) more than a dead cat bounce
Shares of Loyalty Ventures Inc. (NASDAQ:LYLT) last traded at $0.2709, a gain of over +0.1009$ (+59.35%). More than 194,654,676 shares exchanged hands...
MAKE IT MODERN
LATEST REVIEWS
Detmar turns to Hyliion Holdings Corp (NYSE: HYLN) 300 Hypertruck ERX™...
Hyliion Holdings Corp (NYSE: HYLN) has won Detmar’s confidence with its Hypertruck ERX™, which happens to be top-notch technology with the capacity to enable it...
MAKE IT MODERN
PERFORMANCE TRAINING
Nantkwest Inc (NASDAQ:NK) Collaborates With The National Cancer Institute On Natural Killer Cell Research
Nantkwest Inc (NASDAQ:NK) recently announced its collaboration with the National Cancer Institute through which the two are researching the effectiveness of PD-L1 t-haNK Natural...
Altimmune Inc. (NASDAQ:ALT) Submits Investigational New Drug Application for AdCOVID™ COVID-19 Vaccines
Altimmune Inc. (NASDAQ:ALT) has submitted an Investigational New Drug (IND) application to the FDA for the commencement of Phase 1 clinical study...
Social Media Influencer Stocks are Changing the Game (FB, ENGMF, TONJ, SNAP)
The social media influencer space is the future of marketing and branding, a fact made very clear by the recent story of Kylie Cosmetics,...
Crispr Therapeutics AG (NASDAQ: CRSP) Proposes The Addition of Maria Fardis to Its Board
Crispr Therapeutics AG (NASDAQ: CRSP) announced its proposal to place Maria Fardis on the board of directors during the next yearly shareholders’ meeting.
According to...
Palatin Technologies, Inc. (NYSEAMERICAN:PTN) Resumes The Enrollment Of PL9643’s Phase 2 Clinical Study In...
Palatin Technologies, Inc. (NYSEAMERICAN:PTN) announced on Wednesday last week that it has resumed the enrollment of patients in its phase 2 trial of PL9643...
MAKE IT MODERN
